MedTrace Logo

Probiotic Efficacy in VRE Eradication

NCT03560700 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2023-10-03

No results posted yet for this study

Summary

This study will evaluate the efficacy of a probiotic lactobacillus strain in eradicating VRE in non-symptomatic carriers after 4 weeks of treatment. It will also evaluate the long-term efficacy after 8,16 and 24 weeks.

Conditions

  • VRE Colonization

Interventions

DIETARY_SUPPLEMENT

lactobacillus probiotic strain

Approved Dietary supplement

OTHER

placebo

placebo comparator

Sponsors & Collaborators

  • Chr Hansen

    collaborator INDUSTRY

  • Hvidovre University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-07
Primary Completion
2021-11-01
Completion
2021-11-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03560700 on ClinicalTrials.gov